Cimdelirsen sodium
Cimdelirsen is a novel, ligand-conjugated, hepatic-targeted investigative antisense oligonucleotide designed to reduce growth hormone receptor (GHr) synthesis, thereby inhibiting deleterious effects of growth hormone (GH) hypersecretion and reducing circulating insulin-like growth factor-1 (IGF-1) levels in acromegaly patients.
For research use only. We do not sell to patients.
- CAS No.: 2131025-83-5
- Formula: C296H415N83Na20O152P20S15
- Molecular Weight:9128.16
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 2131025-83-5
-
Molecular Weight 9128.16
-
Formula C296H415N83Na20O152P20S15
-
SMILES
[Cimdelirsen (sodium)]
-
Synonyms
ISIS 766720 sodium; IONIS-GHR-LRx sodium
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)